IC
RCKT icon

IEQ Capital’s Rocket Pharmaceuticals RCKT Stock Holding History

IEQ Capital’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.51M Buy
440,255
+58,416
+15% +$194K 0.01% 932
2026
Q1 		$1.37M Buy
381,839
+343,312
+891% +$1.36M 0.01% 915
2025
Q4 		$135K Sell
38,527
-42,650
-53% -$146K ﹤0.01% 1739
2025
Q3 		$265K Buy
81,177
+42,125
+108% +$133K ﹤0.01% 1572
2025
Q2 		$95.7K Buy
39,052
+14,777
+61% +$74.9K ﹤0.01% 1721
2025
Q1 		$162K Buy
+24,275
New +$240K ﹤0.01% 1417

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

IEQ Capital's RCKT Position: Q2 2026 in Review

IEQ Capital increased its Rocket Pharmaceuticals (RCKT) stake by 15% in Q2 2026, buying an estimated $194K and bringing the position to 440,255 shares worth $1.51M. The position accounts for 0.01% of the portfolio, ranked #932.

IEQ Capital first reported a position in RCKT in Q1 2025 and has held it in 6 quarters since. 180 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.

  • IEQ Capital held 440,255 shares of Rocket Pharmaceuticals worth $1.51M as of Q2 2026.
  • IEQ Capital bought 58,416 Rocket Pharmaceuticals shares in Q2 2026, an estimated $194K.
  • Rocket Pharmaceuticals made up 0.01% of IEQ Capital's portfolio in Q2 2026, its #932 holding.
  • IEQ Capital first reported a position in Rocket Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • 180 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.